Clinical efficacy of clarithromycin against uterine cervical and pharyngeal Chlamydia trachomatis and the sensitivity of polymerase chain reaction to detect C. trachomatis at various time points after treatment

Journal of Infection and Chemotherapy

Volumn 9, Issue 3, 2003, Pages 282-283

  Mikamo, Hiroshige ^a   Ninomiya, Mochiyoshi ^a   Tamaya, Teruhiko ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cervix; Chlamydia trachomatis; PCR; Pharynx

Indexed keywords

BACTERIAL DNA; CLARITHROMYCIN;

ARTICLE; BACTERIUM DETECTION; CHLAMYDIASIS; DRUG EFFICACY; ERADICATION THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PHARYNGITIS; POLYMERASE CHAIN REACTION; SEXUAL BEHAVIOR; UTERINE CERVICITIS;

EID: 0142121705     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-003-0253-7     Document Type: Article

References (4)

1. Kojima H, Takai K. Positive rates of Neisseria gonorrhoeae and Chlamydia trachomatis on pharynx and rectum of patients with gonococcal or chlamydial genital infections. Kansenshogaku Zasshi 1994;68:1237-42.
2. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR Recomm Rep 2002;51(RR-6):1-78.
3. Reust CE. SOAP: solutions to often asked problems. Chlamydia trachomatis testing. Arch Fam Med 2000;9:885-6.
4. Gaydos CA, Crotchfelt KA, Howell MR, Kralian S, Hauptman P, Quinn TC. Molecular amplification assays to detect chlamydial infections in urine specimens from high school female students and to monitor the persistence of chlamydial DNA after therapy. J Infect Dis 1998;177:417-24.